Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PETMED EXPRESS INCPETS · Entity 7326 | Director | August 11, 2026 | August 12, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PETMED EXPRESS INC
Report date August 11, 2026 · Filed August 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 90,421 |
Reported balance
After 2026-08-11 transaction · row 1
1 source rowRow 1 · 2026-08-11 · Grant · Acquired 55,555 · Balance 90,421 F1: Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan that vests as to all granted shares on August 11, 2027, subject to continued service on the Board of Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan that vests as to all granted shares on August 11, 2027, subject to continued service on the Board of Directors.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Performant Healthcare Inc
Report date October 21, 2025 · Filed October 21, 2025
Section 16 reporting ended · disclosed 2025-10-21. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-10-21 transaction · row 1
1 source rowRow 1 · 2025-10-21 · Disposition to issuer · Disposed 417,220 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated July 31, 2025 (the "Merger Agreement"), by and among Performant Healthcare, Inc. ("Performant" or "Company"), Continental Buyer, Inc., a Delaware corporation ("Continental" or "Parent") and Prevail Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Continental ("Merger Sub"), pursuant to which Merger Sub will be merged with and into Performant, with Performant surviving the merger as a wholly-owned subsidiary of Continental (the "Merger"). F2: Effective as of immediately prior to the Effective Time (as defined in the Merger Agreement), each share of the Company's Common Stock, par value $0.0001 per share, as the "Common Stock" or "Company Shares" issued and outstanding immediately prior to the Effective Time was canceled and converted into the right to receive $7.75 in cash without interest (the "Merger Consideration") subject to any applicable withholding taxes as provided in the Merger Agreement. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-10-21 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-10-21 · Disposition to issuer · Disposed 35,616 · Balance 0 F3: Effective immediately prior to the Effective Time, each restricted stock unit award (or portion thereof) subject to time-based vesting restrictions, whether vested or unvested, that is outstanding immediately prior to the Effective Time (each, a "Performant RSU") will automatically be canceled in consideration for the right to receive a lump sum cash payment (less any applicable withholding taxes) equal to (i) the total number of Company Shares underlying such Performant RSU multiplied by (ii) the Merger Consideration. F4: All equity awards under the terms of the Company's Amended and Restated 2012 Stock Incentive Plan expire on the tenth anniversary of the original grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger, dated July 31, 2025 (the "Merger Agreement"), by and among Performant Healthcare, Inc. ("Performant" or "Company"), Continental Buyer, Inc., a Delaware corporation ("Continental" or "Parent") and Prevail Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Continental ("Merger Sub"), pursuant to which Merger Sub will be merged with and into Performant, with Performant surviving the merger as a wholly-owned subsidiary of Continental (the "Merger").
F2: Effective as of immediately prior to the Effective Time (as defined in the Merger Agreement), each share of the Company's Common Stock, par value $0.0001 per share, as the "Common Stock" or "Company Shares" issued and outstanding immediately prior to the Effective Time was canceled and converted into the right to receive $7.75 in cash without interest (the "Merger Consideration") subject to any applicable withholding taxes as provided in the Merger Agreement.
F3: Effective immediately prior to the Effective Time, each restricted stock unit award (or portion thereof) subject to time-based vesting restrictions, whether vested or unvested, that is outstanding immediately prior to the Effective Time (each, a "Performant RSU") will automatically be canceled in consideration for the right to receive a lump sum cash payment (less any applicable withholding taxes) equal to (i) the total number of Company Shares underlying such Performant RSU multiplied by (ii) the Merger Consideration.
F4: All equity awards under the terms of the Company's Amended and Restated 2012 Stock Incentive Plan expire on the tenth anniversary of the original grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 11, 2026 Filed Aug 12, 2026 20:19 UTC | PETMED EXPRESS INC PETS · Entity 7326 | GrantCommon Stock | 55,555 | $0.00 | $0.00 |
DisclosureSEC source: 0001040130-26-000034 · wk-form4_1786565948.xml · nonDerivative · entry 1 LaCamp James · CIK 0001794194 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,421 F1 · shares: Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan that vests as to all granted shares on August 11, 2027, subject to continued service on the Board of Directors. Read SEC document |
| October 30, 2025 Filed Nov 3, 2025 21:07 UTC | PETMED EXPRESS INC PETS · Entity 7326 | GrantCommon Stock | 34,866 | $0.00 | $0.00 |
DisclosureSEC source: 0001040130-25-000081 · wk-form4_1762204049.xml · nonDerivative · entry 1 LaCamp James · CIK 0001794194 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,866 F1 · shares: Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan , of which 1,020 shares will vest on October 19, 2026 and 33,846 shares will vest on October 30, 2026, subject to continued service on the Board of Directors. Read SEC document |
| October 21, 2025 Filed Oct 21, 2025 12:08 UTC | Performant Healthcare Inc PHLT · Entity 74046 | Disposition to issuerRestricted Stock Units · Derivative | 35,616 | $7.75 | $276,024.00 |
DisclosureSEC source: 0001550695-25-000105 · wk-form4_1761062879.xml · derivative · entry 2 LaCamp James · CIK 0001794194 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,616 shares Expires not disclosed F3 · derivative.exercise_price: Effective immediately prior to the Effective Time, each restricted stock unit award (or portion thereof) subject to time-based vesting restrictions, whether vested or unvested, that is outstanding immediately prior to the Effective Time (each, a "Performant RSU") will automatically be canceled in consideration for the right to receive a lump sum cash payment (less any applicable withholding taxes) equal to (i) the total number of Company Shares underlying such Performant RSU multiplied by (ii) the Merger Consideration. F3 · derivative.exercise_date: Effective immediately prior to the Effective Time, each restricted stock unit award (or portion thereof) subject to time-based vesting restrictions, whether vested or unvested, that is outstanding immediately prior to the Effective Time (each, a "Performant RSU") will automatically be canceled in consideration for the right to receive a lump sum cash payment (less any applicable withholding taxes) equal to (i) the total number of Company Shares underlying such Performant RSU multiplied by (ii) the Merger Consideration. F4 · derivative.expiration_date: All equity awards under the terms of the Company's Amended and Restated 2012 Stock Incentive Plan expire on the tenth anniversary of the original grant date. F3 · derivative.underlying_shares: Effective immediately prior to the Effective Time, each restricted stock unit award (or portion thereof) subject to time-based vesting restrictions, whether vested or unvested, that is outstanding immediately prior to the Effective Time (each, a "Performant RSU") will automatically be canceled in consideration for the right to receive a lump sum cash payment (less any applicable withholding taxes) equal to (i) the total number of Company Shares underlying such Performant RSU multiplied by (ii) the Merger Consideration. Read SEC document |
| October 21, 2025 Filed Oct 21, 2025 12:08 UTC | Performant Healthcare Inc PHLT · Entity 74046 | Disposition to issuerCommon Stock | 417,220 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001550695-25-000105 · wk-form4_1761062879.xml · nonDerivative · entry 1 LaCamp James · CIK 0001794194 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: Pursuant to the Agreement and Plan of Merger, dated July 31, 2025 (the "Merger Agreement"), by and among Performant Healthcare, Inc. ("Performant" or "Company"), Continental Buyer, Inc., a Delaware corporation ("Continental" or "Parent") and Prevail Merger Sub, Inc., a Delaware corporation and a wholly-owned subsidiary of Continental ("Merger Sub"), pursuant to which Merger Sub will be merged with and into Performant, with Performant surviving the merger as a wholly-owned subsidiary of Continental (the "Merger"). F2 · kind: Effective as of immediately prior to the Effective Time (as defined in the Merger Agreement), each share of the Company's Common Stock, par value $0.0001 per share, as the "Common Stock" or "Company Shares" issued and outstanding immediately prior to the Effective Time was canceled and converted into the right to receive $7.75 in cash without interest (the "Merger Consideration") subject to any applicable withholding taxes as provided in the Merger Agreement. F2 · price: Effective as of immediately prior to the Effective Time (as defined in the Merger Agreement), each share of the Company's Common Stock, par value $0.0001 per share, as the "Common Stock" or "Company Shares" issued and outstanding immediately prior to the Effective Time was canceled and converted into the right to receive $7.75 in cash without interest (the "Merger Consideration") subject to any applicable withholding taxes as provided in the Merger Agreement. Read SEC document |
| July 28, 2025 Filed Jul 28, 2025 17:51 UTC | Performant Healthcare Inc PHLT · Entity 74046 | GrantRestricted Stock Units · Derivative | 35,616 | $0.00 | $0.00 |
DisclosureSEC source: 0001550695-25-000049 · wk-form4_1753739507.xml · derivative · entry 1 LaCamp James · CIK 0001794194 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,616 Underlying: Common Stock · 35,616 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of PHLT's common stock. The units were awarded at no cost to Reporting Person. F2 · derivative.exercise_date: Restricted Stock Unit Award was granted on July 28, 2025. The Restricted Stock Units will vest with respect to 100% of the shares subject to the award on the earlier of the Registrant's 2026 annual meeting of stockholders or a Change in Control (as defined in the Registrant's Amended and Restated 2012 Stock Incentive Plan). The restricted stock units may be settled only for shares of common stock on a one-for-one basis. F2 · derivative.expiration_date: Restricted Stock Unit Award was granted on July 28, 2025. The Restricted Stock Units will vest with respect to 100% of the shares subject to the award on the earlier of the Registrant's 2026 annual meeting of stockholders or a Change in Control (as defined in the Registrant's Amended and Restated 2012 Stock Incentive Plan). The restricted stock units may be settled only for shares of common stock on a one-for-one basis. F2 · balance_after: Restricted Stock Unit Award was granted on July 28, 2025. The Restricted Stock Units will vest with respect to 100% of the shares subject to the award on the earlier of the Registrant's 2026 annual meeting of stockholders or a Change in Control (as defined in the Registrant's Amended and Restated 2012 Stock Incentive Plan). The restricted stock units may be settled only for shares of common stock on a one-for-one basis. Read SEC document |
| July 30, 2024 Filed Aug 1, 2024 16:40 UTC | Performant Healthcare Inc PFMT · Entity 74046 | GrantRestricted Stock Units · Derivative | 36,011 | $0.00 | $0.00 |
DisclosureSEC source: 0001550695-24-000057 · wk-form4_1722544841.xml · derivative · entry 1 LaCamp James · CIK 0001794194 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,011 Underlying: Common Stock · 36,011 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of PFMT's common stock. The units were awarded at no cost to Reporting Person. F2 · derivative.exercise_date: Restricted Stock Unit Award was granted on July 30, 2024. The Restricted Stock Units will vest with respect to 100% of the shares subject to the award on the earlier of the Registrant's 2025 annual meeting of stockholders or a Change in Control (as defined in the Registrant's Amended and Restated 2012 Stock Incentive Plan). The restricted stock units may be settled only for shares of common stock on a one-for-one basis. F2 · derivative.expiration_date: Restricted Stock Unit Award was granted on July 30, 2024. The Restricted Stock Units will vest with respect to 100% of the shares subject to the award on the earlier of the Registrant's 2025 annual meeting of stockholders or a Change in Control (as defined in the Registrant's Amended and Restated 2012 Stock Incentive Plan). The restricted stock units may be settled only for shares of common stock on a one-for-one basis. F2 · balance_after: Restricted Stock Unit Award was granted on July 30, 2024. The Restricted Stock Units will vest with respect to 100% of the shares subject to the award on the earlier of the Registrant's 2025 annual meeting of stockholders or a Change in Control (as defined in the Registrant's Amended and Restated 2012 Stock Incentive Plan). The restricted stock units may be settled only for shares of common stock on a one-for-one basis. Read SEC document |
| January 19, 2024 Filed Jan 22, 2024 19:48 UTC | Performant Healthcare Inc PFMT · Entity 74046 | GrantRestricted Stock Units · Derivative | 27,675 | $0.00 | $0.00 |
DisclosureSEC source: 0001550695-24-000003 · wk-form4_1705970881.xml · derivative · entry 1 LaCamp James · CIK 0001794194 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,675 Underlying: Common Stock · 27,675 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of PFMT's common stock. The units were awarded at no cost to Reporting Person. F2 · derivative.exercise_date: Restricted Stock Unit Award was granted on January 19, 2024. The Restricted Stock Units will vest with respect to 100% of the shares subject to the award on the earlier of the Registrant's 2024 annual meeting of stockholders or a Change in Control (as defined in the Registrant's Amended and Restated 2012 Stock Incentive Plan). The restricted stock units may be settled only for shares of common stock on a one-for-one basis. F2 · derivative.expiration_date: Restricted Stock Unit Award was granted on January 19, 2024. The Restricted Stock Units will vest with respect to 100% of the shares subject to the award on the earlier of the Registrant's 2024 annual meeting of stockholders or a Change in Control (as defined in the Registrant's Amended and Restated 2012 Stock Incentive Plan). The restricted stock units may be settled only for shares of common stock on a one-for-one basis. F2 · balance_after: Restricted Stock Unit Award was granted on January 19, 2024. The Restricted Stock Units will vest with respect to 100% of the shares subject to the award on the earlier of the Registrant's 2024 annual meeting of stockholders or a Change in Control (as defined in the Registrant's Amended and Restated 2012 Stock Incentive Plan). The restricted stock units may be settled only for shares of common stock on a one-for-one basis. Read SEC document |
| August 26, 2022 Filed Aug 29, 2022 18:57 UTC | Performant Healthcare Inc PFMT · Entity 74046 | GrantRestricted Stock Units · Derivative | 35,377 | $0.00 | $0.00 |
DisclosureSEC source: 0001550695-22-000061 · wf-form4_166181380488136.xml · derivative · entry 1 LaCamp James · CIK 0001794194 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,377 Underlying: Common Stock · 35,377 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of PFMT's common stock. The units were awarded at no cost to Reporting Person. F2 · derivative.exercise_date: Restricted Stock Unit Award was granted on August 26, 2022. The Restricted Stock Units will vest with respect to 100% of the shares subject to the award on the earlier of the Registrant's 2023 annual meeting of stockholders or a Change in Control (as defined in the Registrant's Amended and Restated 2012 Stock Incentive Plan). The restricted stock units may be settled only for shares of common stock on a one-for-one basis. F2 · derivative.expiration_date: Restricted Stock Unit Award was granted on August 26, 2022. The Restricted Stock Units will vest with respect to 100% of the shares subject to the award on the earlier of the Registrant's 2023 annual meeting of stockholders or a Change in Control (as defined in the Registrant's Amended and Restated 2012 Stock Incentive Plan). The restricted stock units may be settled only for shares of common stock on a one-for-one basis. F2 · balance_after: Restricted Stock Unit Award was granted on August 26, 2022. The Restricted Stock Units will vest with respect to 100% of the shares subject to the award on the earlier of the Registrant's 2023 annual meeting of stockholders or a Change in Control (as defined in the Registrant's Amended and Restated 2012 Stock Incentive Plan). The restricted stock units may be settled only for shares of common stock on a one-for-one basis. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 19:13 UTC | Performant Healthcare Inc PFMT · Entity 74046 | GrantRestricted Stock Units · Derivative | 16,741 | $0.00 | $0.00 |
DisclosureSEC source: 0001550695-21-000072 · wf-form4_163071078145941.xml · derivative · entry 1 LaCamp James · CIK 0001794194 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,741 Underlying: Common Stock · 16,741 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of PFMT's common stock. The units were awarded at no cost to Reporting Person. F2 · derivative.exercise_date: Restricted Stock Unit Award was granted on September 1, 2021. The Restricted Stock Units will vest with respect to 100% of the shares subject to the award on the earlier of the Registrant's 2022 annual meeting of stockholders or a Change in Control (as defined in the Registrant's Amended and Restated 2012 Stock Incentive Plan). The restricted stock units may be settled only for shares of common stock on a one-for-one basis. F2 · derivative.expiration_date: Restricted Stock Unit Award was granted on September 1, 2021. The Restricted Stock Units will vest with respect to 100% of the shares subject to the award on the earlier of the Registrant's 2022 annual meeting of stockholders or a Change in Control (as defined in the Registrant's Amended and Restated 2012 Stock Incentive Plan). The restricted stock units may be settled only for shares of common stock on a one-for-one basis. F2 · balance_after: Restricted Stock Unit Award was granted on September 1, 2021. The Restricted Stock Units will vest with respect to 100% of the shares subject to the award on the earlier of the Registrant's 2022 annual meeting of stockholders or a Change in Control (as defined in the Registrant's Amended and Restated 2012 Stock Incentive Plan). The restricted stock units may be settled only for shares of common stock on a one-for-one basis. Read SEC document |
| July 30, 2020 Filed Aug 3, 2020 19:09 UTC | Performant Healthcare Inc PFMT · Entity 74046 | GrantRestricted Stock Units · Derivative | 117,206 | $0.00 | $0.00 |
DisclosureSEC source: 0001550695-20-000071 · wf-form4_159649616780520.xml · derivative · entry 1 LaCamp James · CIK 0001794194 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,206 Underlying: Common Stock · 117,206 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of PFMT's common stock. The units were awarded at no cost to Reporting Person. F2 · derivative.exercise_date: Restricted Stock Unit Award was granted on July 30, 2020. The Restricted Stock Units will vest with respect to 100% of the shares subject to the award on the earlier of the Registrant's 2021 annual meeting of stockholders or a Change in Control (as defined in the Registrant's Amended and Restated 2012 Stock Incentive Plan). The restricted stock units may be settled only for shares of common stock on a one-for-one basis. F2 · derivative.expiration_date: Restricted Stock Unit Award was granted on July 30, 2020. The Restricted Stock Units will vest with respect to 100% of the shares subject to the award on the earlier of the Registrant's 2021 annual meeting of stockholders or a Change in Control (as defined in the Registrant's Amended and Restated 2012 Stock Incentive Plan). The restricted stock units may be settled only for shares of common stock on a one-for-one basis. F2 · balance_after: Restricted Stock Unit Award was granted on July 30, 2020. The Restricted Stock Units will vest with respect to 100% of the shares subject to the award on the earlier of the Registrant's 2021 annual meeting of stockholders or a Change in Control (as defined in the Registrant's Amended and Restated 2012 Stock Incentive Plan). The restricted stock units may be settled only for shares of common stock on a one-for-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.